Showing results (1121-1130 of 1,193) with videos related to

Sort By:
Pageof 120
The Lancet. Haematology|December 22, 2023
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 studyGuillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Aberrant oxidative metabolism selects for TET2 -deficient hematopoietic stem and progenitor cellsKatia E Niño, Vera Adema, Alyx E Gray, et al.
Cancer|April 22, 2022
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort studyAjay Sheshadri, Alberto A Goizueta, Vickie R Shannon, et al.
Journal of the American Society of Nephrology : JASN|November 17, 2006
International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortalityMaki Yoshino, Martin K Kuhlmann, Peter Kotanko, et al.
Blood Cancer Discovery|July 3, 2025
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease StatesCurtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, et al.
Nature Plants|July 4, 2024
Global needs for nitrogen fertilizer to improve wheat yield under climate changePierre Martre, Sibylle Dueri, Jose Rafael Guarin, et al.
Blood Advances|July 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasmsOriol Calvete, Julia Mestre, Lorea Chaparro-González, et al.
Leukemia Research|September 17, 2018
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDSYasushi Miyazaki, Heinz Tuechler, Guillermo Sanz, et al.
Blood|June 24, 2016
Time-dependent changes in mortality and transformation risk in MDSMichael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, et al.
Nature Communications|October 19, 2021
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapyHussein A Abbas, Dapeng Hao, Katarzyna Tomczak, et al.
Pageof 120